Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Merit Medical SystemsMMSI +3.04%83 Equity-to-Asset is 0.59 as of Jun. 2026, which is 2% above its 10-year median of 0.58. GuruFocus rates MMSI with a GF Score™ of 83/100 and a GF Value™ of $96.00 (Fairly Valued). The stock has 2 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Merit Medical Systems ranks worse than 56.64% on this metric.
Merit Medical Systems (NAS:MMSI) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Merit Medical Systems Equity-to-Asset Related Terms
Merit Medical Systems Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Merit Medical Systems's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MMSI vs NVST, MMED, ICUI: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merit Medical Systems Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Merit Medical Systems's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Merit Medical Systems's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merit Medical Systems (MMSI) has a Equity-to-Asset of 0.59 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Merit Medical Systems and its competitors. This is near median its historical median of 0.58. Over the past decade, Merit Medical Systems' Equity-to-Asset has ranged from 0.52 to 0.71. According to the industry distribution chart, Merit Medical Systems ranks #482 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 56.6%.
Is Merit Medical Systems' Equity-to-Asset too high?
Merit Medical Systems' current Equity-to-Asset of 0.59 is near median its 10-year median of 0.58. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 0.71. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Merit Medical Systems' value of 0.59 is 7.8% below this industry median. Based on the distribution chart, Merit Medical Systems ranks #482 out of 851 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Merit Medical Systems has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' Equity-to-Asset compare to NVST and MMED?
According to the Medical Devices & Instruments industry distribution chart, Merit Medical Systems ranks #482 out of 851 companies for Equity-to-Asset. This places Merit Medical Systems in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Merit Medical Systems' value of 0.59 is 7.8% below this benchmark. Historically, Merit Medical Systems' own Equity-to-Asset has ranged from 0.52 to 0.71 over the past decade. While the company's 10-year median is 0.58 vs. the industry median of 0.64, Merit Medical Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Merit Medical Systems's current Equity-to-Asset of 0.59 is 7.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Merit Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merit Medical Systems's current Equity-to-Asset is 0.59, which is near median its own 10-year median of 0.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Merit Medical Systems (MMSI) is currently considered Fairly Valued. The stock's GF Value™ is $96.00, compared to a current price of $91.98 — trading 4.2% below its estimated fair value. The current Equity-to-Asset is 0.59, which is near median its 10-year median of 0.58 and 7.8% below the Medical Devices & Instruments industry median of 0.64. Merit Medical Systems' overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Merit Medical Systems (MMSI), the current Equity-to-Asset is 0.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merit Medical Systems (MMSI) Overvalued in 2026?
Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued.
The current stock price of $91.98 is trading 4.2% below its estimated GF Value™ of $96.00.
GuruFocus considers Merit Medical Systems to be Fairly Valued.
Key valuation signals for MMSI:
Equity-to-Asset: 0.59 (near median its 10-year median of 0.58)
GF Value™: $96.00 vs. price of $91.98 (4.2% below fair value)
Industry Position: 7.8% below the Medical Devices & Instruments median (#482 of 851)
No single metric tells the full story. See the MMSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
83GF Score
Get the complete analysis for MMSI
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MMSI has been successfully added to your 
